Thyroid
Breast-INV | Breast-DCIS
Lung
Esophagus | Stomach | Colon | Pancreas
Endometrium | Cervix
Prostate | Kidney | Renal Pelvis and Ureter | Bladder | Testis
GIST | Skin


Prostate Biopsies

IHC table: TUO Mucinous Carcinomas
IHC table: Carcinomas of Unknown Origin
IHC table: Renal Carcinomas
IHC table: Germ Cell Tumors
Fields to view based on lens diameter
Molecular and IHC Tests
Download sorted Breast Prognostic Stage Groups table
Notification Contacts

Colon Carcinoma Worksheet 4.0.0.1

NOTE: revised, but not tested in depth. Please double check and report any issues. thanks.

Specimen Data
Procedure







Specimen








Intactness of Mesorectum (optional)




Macroscopic Tumor Perforation


Tumor Data
Histologic Tumor Type:












Main Tumor










Location of Tumor (Optional, Rectal Primaries only)


(Second Tumor Site)









Microscopic Tumor Extension







Tumor Differentiation







Perineural Invasion
Angiolymphatic Invasion

Tumor Budding (optional; recommended for polyps and stage I/II cases)








Margins
(-) Clear (+) Invasive (+) In Situ (+) Adenoma
Proximal Margin
Distal Margin
Radial/Mesenteric Margin
Peripheral Margin **

* positive radial/mesenteric margin defined as invasive tumor <= 0.1 cm from margin
** applies only to trans-anal disk excisions

Staging
Lymph Node Status Note: Isolated tumor cells are N0, but their presence and number of nodes should be mentioned in a comment. Note: Micrometastases are N1. Use of N1mi is optional, but not required.


lymph nodes.
of nodes.






Metastatic Disease

Tissue submitted and NEGATIVE for metastatic disease
Tissue submitted and POSITIVE for metastatic disease
Miscellaneous
Treatment Effect





Modifiers






Other Findings







Comments







Free-text Comments





MRP Testing
Prior case #:
Results:MLH1
MSH2
MSH6
PMS2
KRAS Testing
Prior case #:
Select detected mutations:

















BRAF Testing
Prior case #:
Select detected mutations:






Final Report